Cargando…
A Randomized, Double-blind, Placebo-controlled Trial of Celecoxib Augmentation of Sertraline in Treatment of Drug-naive Depressed Women: A Pilot Study
This study was designed to examine the antidepressant effect of celecoxib (200 mg/day) augmentation of sertraline in the treatment of female patients with first episode of major depression over 8 weeks of therapy. Thirty female outpatients diagnosed with first episode of major depression, were recru...
Autores principales: | Majd, Marzieh, Hashemian, Farshad, Hosseini, Seyed Mohammad, Vahdat Shariatpanahi, Maryam, Sharifi, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4518118/ https://www.ncbi.nlm.nih.gov/pubmed/26330878 |
Ejemplares similares
-
Bosentan for high-risk outpatients with COVID-19 infection: a randomized, double blind, placebo-controlled trial
por: Shahbazi, Shaahin, et al.
Publicado: (2023) -
Agomelatine augmentation of sertraline in the treatment of moderate to severe obsessive-compulsive disorder: a randomized double-blinded placebo-controlled clinical trial
por: Shokrani, Marjan, et al.
Publicado: (2023) -
Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial
por: Askari, Sanaz, et al.
Publicado: (2022) -
Granisetron-mediated augmentation of sertraline therapeutic effect in obsessive-compulsive disorder: a double-blind placebo-controlled, randomized clinical trial
por: Ghobadian, Ala, et al.
Publicado: (2022) -
Effects of Passion Flower Extract, as an Add-On Treatment to Sertraline, on Reaction Time in Patients with Generalized Anxiety Disorder: A Double-Blind Placebo-Controlled Study
por: Nojoumi, Mandana, et al.
Publicado: (2016)